{"entity":{"id":"anirban-maitra","kind":"person","name":"Anirban Maitra","aka":[],"tldr":"Anirban Maitra is a pancreatic cancer pathologist working on catching the disease early and understanding its precursors.","summary":"Anirban Maitra is Scientific Director of the Sheikh Ahmed Center for Pancreatic Cancer Research at MD Anderson Cancer Center. A pathologist and pancreatic cancer researcher, he leads early-detection efforts including the pancreatic cancer risk and cyst programmes, and studies the biology of pancreatic precursor lesions and KRAS-driven tumorigenesis. His papers include a Gastroenterology review of the opportunities and challenges in early detection of pancreatic cancer and a Modern Pathology analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray. His work connects pancreatic ductal adenocarcinoma pathology to multi-cancer early detection and liquid biopsy.","asOf":"2026-09-08","links":[{"label":"MD Anderson faculty","url":"https://faculty.mdanderson.org/search?q=Anirban%20Maitra"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Maitra%20A%5BAuthor%5D"},{"label":"Google Scholar","url":"https://scholar.google.com/scholar?q=Anirban%20Maitra"}],"tags":[],"related":[],"cancers":["pancreatic"],"sections":[],"technologies":["mced","liquid-biopsy"],"targets":["kras"],"drugs":[],"companies":[],"institutions":["md-anderson"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Scientific Director, Sheikh Ahmed Center for Pancreatic Cancer Research, MD Anderson","institutionId":"md-anderson","specialisms":["Pancreatic cancer","Early detection","Cancer pathology"],"profiles":[{"label":"MD Anderson faculty","url":"https://faculty.mdanderson.org/search?q=Anirban%20Maitra"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Maitra%20A%5BAuthor%5D"},{"label":"Google Scholar","url":"https://scholar.google.com/scholar?q=Anirban%20Maitra"}],"papers":[{"title":"Early Detection of Pancreatic Cancer: Opportunities and Challenges","journal":"Gastroenterology","year":2019,"url":"https://doi.org/10.1053/j.gastro.2019.01.259","doi":"10.1053/j.gastro.2019.01.259"},{"title":"Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray","journal":"Modern Pathology","year":2003,"url":"https://doi.org/10.1097/01.MP.0000086072.56290.FB","doi":"10.1097/01.MP.0000086072.56290.FB"}]},"route":"/people/anirban-maitra/","neighbours":{"cancer":[{"id":"ipmn-cystic-precursors","kind":"cancer","name":"Intraductal papillary mucinous neoplasm and other pancreatic cystic precursors","route":"/cancers/ipmn-cystic-precursors/"},{"id":"kras-wild-type-pdac","kind":"cancer","name":"KRAS wild-type pancreatic ductal adenocarcinoma","route":"/cancers/kras-wild-type-pdac/"},{"id":"pancreatic-acinar-cell-carcinoma","kind":"cancer","name":"Pancreatic acinar cell carcinoma","route":"/cancers/pancreatic-acinar-cell-carcinoma/"},{"id":"pancreatic","kind":"cancer","name":"Pancreatic ductal adenocarcinoma","route":"/cancers/pancreatic/"}],"technology":[{"id":"liquid-biopsy","kind":"technology","name":"Liquid biopsy (ctDNA)","route":"/technologies/liquid-biopsy/"},{"id":"mced","kind":"technology","name":"Multi-cancer early detection (MCED)","route":"/technologies/mced/"}],"target":[{"id":"kras","kind":"target","name":"KRAS","route":"/targets/kras/"}],"institution":[{"id":"md-anderson","kind":"institution","name":"MD Anderson Cancer Center","route":"/institutions/md-anderson/"}],"paper":[{"id":"paper-bernard-ctdna-exodna-pancreatic-gastroenterology-2019","kind":"paper","name":"Circulating nucleic acids are associated with outcomes of patients with pancreatic cancer","route":"/key-papers/paper-bernard-ctdna-exodna-pancreatic-gastroenterology-2019/"},{"id":"paper-jones-pancreatic-core-pathways-science-2008","kind":"paper","name":"Core signaling pathways in human pancreatic cancers revealed by global genomic analyses","route":"/key-papers/paper-jones-pancreatic-core-pathways-science-2008/"},{"id":"paper-fahrmann-ca19-9-lead-time-gastroenterology-2021","kind":"paper","name":"Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection","route":"/key-papers/paper-fahrmann-ca19-9-lead-time-gastroenterology-2021/"},{"id":"paper-kanda-panin-1-somatic-mutations-gastroenterology-2012","kind":"paper","name":"Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia","route":"/key-papers/paper-kanda-panin-1-somatic-mutations-gastroenterology-2012/"},{"id":"paper-singhi-targeted-genome-profiling-3594-pdac-gastroenterology-2019","kind":"paper","name":"Real-time targeted genome profile analysis of pancreatic ductal adenocarcinomas identifies genetic alterations that might be targeted with existing drugs or used as biomarkers","route":"/key-papers/paper-singhi-targeted-genome-profiling-3594-pdac-gastroenterology-2019/"},{"id":"paper-wu-gnas-ipmn-sci-transl-med-2011","kind":"paper","name":"Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development","route":"/key-papers/paper-wu-gnas-ipmn-sci-transl-med-2011/"}],"roadmap":[{"id":"pancreatic-roadmap","kind":"roadmap","name":"Pancreatic cancer roadmap: from Whipple's operation to gemcitabine, FOLFIRINOX, adjuvant chemotherapy, PARP inhibition, KRAS inhibition, vaccines and the surveillance question","route":"/roadmaps/pancreatic-roadmap/"}]}}